Get the Daily Brief
Latest Biotech News
New Metabolic Syndrome Score Validated for Adolescents
A novel continuous metabolic syndrome risk score (msRS) tailored for adolescents has been introduced and validated through confirmatory factor analysis. This dynamic metric allows more accurate...
Merck’s Injectable Keytruda Scores FDA Nod – Cuts Dosing Time
Merck's injectable formulation of the blockbuster cancer immunotherapy Keytruda, branded Keytruda Qlex, has gained FDA approval. This new injectable form can be administered in minutes,...
Seven Starling Nets $8M to Expand Maternal Mental Healthcare
Seven Starling, a digital maternal mental health company, secured $8 million in a funding round led by Rethink Impact, with participation from Pear VC, Zeal Capital Partners, and others including...
Agentic AI Enters Healthcare Legal Gray Zone, Expert Warns
Agentic artificial intelligence systems are gaining ground in healthcare applications but raise significant concerns around liability and patient safety. Legal expert Lily Li, founder of Metaverse...
Breakthrough TMolNet AI Model Enhances Molecular Property Prediction
Researchers led by Han, Tang, and Lu have introduced TMolNet, a novel task-aware multimodal neural network designed to improve accuracy in predicting molecular properties. This machine learning...
CAR T and TIL Therapies Advance in Gastrointestinal Cancer Fight
Innovations in immunotherapy, including chimeric antigen receptor T-cell (CAR T-cell) and tumor-infiltrating lymphocyte (TIL) therapies, are emerging as promising treatments for gastrointestinal...
New Insights Link Night Shifts to Elevated Health Risks
Studies increasingly confirm that night shift work disrupts circadian rhythms, leading to a host of adverse health outcomes including cardiometabolic, autoimmune disorders, and certain cancers....
Ants’ Genetic Tactic Enables Superior Olfactory Precision
Researchers have uncovered that ants maintain exceptional olfactory clarity through a genetic mechanism that silences neighboring receptor genes, preventing cross-activation. This discovery...
Bisabolol Emerges as Potent Natural Anticancer Agent
Bisabolol, a naturally occurring sesquiterpene alcohol, demonstrates selective cytotoxicity against various cancer cell lines, revealing its multifaceted potential as an anticancer agent....
Pediatric Study Links CT Scans to Increased Cancer Risks
A recent investigation in the Journal of Medical Biology Engineering exposes concerning associations between abdominal and pelvic CT scans in children and heightened risks for malignancies and...
Nanoparticles Advance Multimodal Imaging and Therapy at Stanford
Giovanni Marco Saladino, a postdoctoral scholar at Stanford University, is developing innovative multimodal nanoparticles that enable simultaneous imaging via MRI and X-ray fluorescence. These...
FDA Clears Stealth Therapeutics’ Barth Syndrome Therapy
The FDA has granted approval to Stealth Therapeutics' therapy targeting Barth syndrome, marking the first mitochondria-targeted treatment available for this rare genetic disorder. This regulatory...
Subcutaneous Keytruda Gains FDA and CHMP Backing
Both the FDA and the European CHMP have recommended and approved subcutaneous formulations of Keytruda, streamlining administration of this widely used cancer immunotherapy. This approval,...
Dualitas Raises $65 Million for Bispecific Autoimmune Drugs
Dualitas Therapeutics secured $65 million in Series A funding to advance its bispecific antibody platform, which targets two immune cell receptors simultaneously for enhanced modulation in...
GenFleet IPO Doubles on Hong Kong Market Debut
GenFleet’s shares doubled in their first day of trading on the Hong Kong Exchange, signaling strong investor appetite for biotech equities in the region. This IPO continues the momentum of biotech...
MapLight Files IPO to Fund Schizophrenia and Alzheimer’s R&D
MapLight Therapeutics has filed for an initial public offering to support development of novel treatments targeting schizophrenia and Alzheimer's disease. The company’s pipeline focuses on...
Han et al Introduce TMolNet for Molecular Property Prediction
A new multimodal neural network, TMolNet, has been developed to improve molecular property prediction, integrating task-awareness and chemical modalities. Led by Han, Tang, and Lu, this AI-driven...
CAR T Therapy Access Hinges on Managing Toxicities
The expansion of CAR T-cell therapies faces hurdles due to toxicity management challenges such as cytokine release syndrome and neurotoxicity. Experts stress the need for improved strategies to...
AI Insights Extend Lithium-Ion Battery Lifespans
Researchers have applied artificial intelligence to estimate remaining useful life of lithium-ion batteries with greater precision. This advancement supports longer device performance and more...
University of Arizona, UNM Awarded $43.6M NIH Grant
The NIH has granted $43.6 million over seven years to the University of Arizona and University of New Mexico to enhance translational clinical research. This collaborative project aims to improve...